Table 5.
Mean and SD for the secondary outcomes at admission (T1), immediately after treatment (T2), and 3 months after the intervention period (T3) for completers.
| Secondary outcome measure (scale) | T1a | T2a | T3a | ||||||||||||||
|
|
Median (IQR) | Mean (SD) |
P value |
Median (IQR) | Mean (SD) |
P value |
Median (IQR) | Mean (SD) |
P value |
||||||||
| CPAQb | .07 |
|
|
.14 |
|
|
.47 | ||||||||||
|
|
Control | 68.0 (58.0-78.0) | 66.77 (18.4)c |
|
65.5 (52.75-72.5) | 63.82 (12.47)d |
|
65.0 (54.5-71.5) | 65.67 (16.06)e |
|
|||||||
|
|
Intervention | 63.0 (53.75-71.0) | 64.16 (18.89)f |
|
67.0 (59.0-78.0) | 68.23 (14.43)g |
|
62.0 (54.5-73.0) | 64.48 (21.76)h |
|
|||||||
| EQ-5D | .27 |
|
|
.008 |
|
|
.30 | ||||||||||
|
|
Control | 0.46 (0.22-0.59) | 0.43 (0.21)c |
|
0.36 (0.22-0.56) | 0.41 (0.22)d |
|
0.37 (0.22-0.52) | 0.39 (0.19)e |
|
|||||||
|
|
Intervention | 0.48 (0.23-0.59) | 0.45 (0.19)f |
|
0.56 (0.47-0.72) | 0.55 (0.17)g |
|
0.41 (0.22-0.59) | 0.43 (0.2)h |
|
|||||||
| EQ-VASi | .16 |
|
|
.02 |
|
|
.03 | ||||||||||
|
|
Control | 44.0 (21.5-54.0) | 44.23 (23.49)j |
|
35.0 (25.25-56.0) | 38.68 (19.58)g |
|
30.0 (25.0-51.0) | 36.96 (20.15) |
|
|||||||
|
|
Intervention | 47.0 (33.5-60.0) | 48.22 (18.74)k |
|
53.0 (38.0-66.0) | 52.68 (18.27)l |
|
50.0 (31.5-75.0) | 51.05 (25.73)l |
|
|||||||
aAt admission to the program (T1), at the end of the intervention at 6 to 7 weeks (T2), and at the 3-month follow-up (T3).
bCPAQ: Chronic Pain Acceptance Questionnaire.
cn=53.
dn=28.
en=27.
fn=56.
gn=22.
hn=23.
iEQ-VAS: EuroQol Visual Analogue Scale.
jn=47.
kn=50.
ln=19.